.png)
At Oxymed Hospital, we are committed to pioneering advancements in cardiovascular health through rigorous research and evidence-based practices. Our dedication to innovation is exemplified by the groundbreaking work of Dr. Sama Akber, whose research has significantly contributed to the understanding and treatment of refractory angina and heart failure symptoms.
Dr. Sama Akber's Study: Investigating the Impact of EECP on Left Ventricular Function
Dr. Sama Akber, a distinguished cardiologist and researcher at Oxymed Hospital, conducted a seminal study on the efficacy of Enhanced External Counterpulsation (EECP) in patients with refractory angina and heart failure symptoms. Her study aimed to assess the effects of EECP on left ventricular (LV) function, a critical indicator of heart health.
Key Findings and Therapeutic Benefits of EECP
The findings of Dr. Sama Akber's research were nothing short of remarkable. Through meticulous analysis, utilizing cutting-edge techniques such as strain analysis, Dr. Akber demonstrated significant improvements in LV function among patients undergoing EECP therapy. These findings not only underscored the therapeutic benefits of EECP but also highlighted its potential to enhance cardiovascular outcomes in individuals with refractory angina and heart failure.
EECP Heart Care at Oxymed Hospital: Setting a New Standard
At Oxymed Hospital, we take pride in offering state-of-the-art EECP heart care, informed by cutting-edge research and clinical expertise. Dr. Sama Akber's groundbreaking study serves as a testament to our unwavering commitment to excellence in cardiovascular health. Through the integration of research-backed interventions like EECP, we continue to shape the future of cardiovascular care, one patient at a time.
Experience the difference of research-driven excellence in cardiovascular health at Oxymed Hospital, where innovation meets compassionate care.
.svg){kind=avatar}
Amit Gupta
Chitra
Muthu Kumar
Muthu Kumar
.svg)
.svg)
.svg)
.svg)
.svg)
.png)
.png)
.png)